Some 23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long COVID, and in more than half of them the ...

The man’s case didn’t give rise to any widespread variant, but it gave Gupta, with his HIV evolution background, the idea ...

“The effectiveness of the COVID vaccines can vary depending on which variants are targeted in the vaccine, which variants are circulating, and host factors,” said Shirin A. Mazumder, MD, and ...

According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID. Long-COVID continues to impact many, with symptoms lasting years in some cases.

Another recent federal study, published in the journal JAMA Pediatrics in February, showed approximately 1.01 million ...

The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.

Five years after the Covid pandemic, health experts are finally ready to say that it’s over - With deaths and ...

SARS-CoV-2 has been evolving the ability to evade the immune system about twice as fast as the fastest-evolving flu virus. It ...

The virus that causes COVID-19 continues to mutate. Scientists say that's likely to continue indefinitely, and the virus will ...

Monoclonal antibodies like etesevimab have lost efficacy against Omicron subvariants, necessitating innovative solutions.

Before the COVID pandemic, wastewater sampling wasn't routinely done for public health purposes. But as the case number ...

Five years have passed since the COVID-19 pandemic first emerged. It began in December 2019 with an outbreak in Wuhan, China, ...